Yang, C., Yang, C., Ou, H., & Kuo, S. (2020). Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: A nationwide population-based cohort study. Cardiovasc Diabetol.
Stile di citazione ChicagoYang, Chun-Ting, Chen-Yi Yang, Huang-Tz Ou, e Shihchen Kuo. "Comparative Cardiovascular Safety of GLP-1 Receptor Agonists Versus Other Glucose-lowering Agents in Real-world Patients With Type 2 Diabetes: A Nationwide Population-based Cohort Study." Cardiovasc Diabetol 2020.
Citazione MLAYang, Chun-Ting, Chen-Yi Yang, Huang-Tz Ou, e Shihchen Kuo. "Comparative Cardiovascular Safety of GLP-1 Receptor Agonists Versus Other Glucose-lowering Agents in Real-world Patients With Type 2 Diabetes: A Nationwide Population-based Cohort Study." Cardiovasc Diabetol 2020.